CLINICAL_TRIALS
research
· 2024-07-31
Clinical Trial Update: Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML) [Phase 1]
Summary
A Phase 1 trial of HS-10382 in combination therapy for chronic myeloid leukemia is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Myelogenous Leukemia, CML Chronic Phase | Phase 1 | Status: NOT_YET_RECRUITING